Pharmacological comparison of the alternatively spliced short and long CCK 2 receptors

British Journal of Pharmacology

Volumn 140, Issue 1, 2003, Pages 218-224

  Morton, M F ^a,c   Harper, E A ^b   Tavares, I A ^a   Shankley, N P ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b James Black Foundation   (United Kingdom)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

3H JB93182; CCK 2 receptor; Cholecystokinin; G 1 and G 2 receptors; Human; Short and long isoforms

Indexed keywords

1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2' PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; 5 [[[[[(3,5 DICARBOXYPHENYL)AMINO]CARBONYL] 2 PHENYLETHYL]AMINO]CARBONYL] 6 [[(1 AMADANTYLMETHYL)AMINO]CARBONYL]INDOLE; 6 [[(1 ADAMANTYLMETHYL)AMINO]CARBONYL] 5 [[1 [[(3,5 DICARBOXYPHENYL)AMINO]CARBONYL] 2 PHENYLETHYLAMINO]CARBONYL]INDOLE; CHOLECYSTOKININ 2L RECEPTOR; CHOLECYSTOKININ 2S RECEPTOR; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; L 365 260; L 365 320; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; YM 220;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BINDING ASSAY; CELL STRAIN 3T3; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; GENE EXPRESSION; INCUBATION TIME; MOUSE; NONHUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; STRUCTURE ANALYSIS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDOLES; MICE; NIH 3T3 CELLS; PROTEIN BINDING; RECEPTOR, CHOLECYSTOKININ B;

EID: 0141730363     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705423     Document Type: Article

References (22)

1. BEINBORN, M., QUINN, S.M. & KOPIN, A.S. (1998). Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties. J. Biol. Chem., 273, 14146-14151.
2. BELLIER, B., MCCORT TRANCHEPAIN, I., DUCOS, B., DANASCIMENTO, S., MEUDAL, H., NOBLE, F., GARBAY, C. & ROQUES, B.P. (1997). Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells. J. Med. Chem., 40, 3947-3956.
3. BIAGINI, P., MONGES, G., VUAROQUEAUX, V., PARRIAUX, D., CANTALOUBE, J.F. & DE MICCO, P. (1997). The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines. Life Sci., 61, 1009-1018.
4. BLAKER, M., REN, Y., GORDON, M.C., HSU, J.E., BEINBORN, M. & KOPIN, A.S. (1998). Mutation within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists. Mol. Pharmacol., 54, 857-863.
5. CHENG, Y. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
6. DENYER, J., GRAY, J., WONG, M., STOLZ, M. & TATE, S. (1994). Molecular and pharmacological characterization of the human CCKB receptor. Eur. J. Pharmacol., 268, 29-41.
7. DING, X.Q., CHEN, D. & HAKANSON, R. (1995). Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase. Gastroenterology, 109, 1181-1187.
8. DURIEUX, C., COPPEY, M., ZAJAC, J.M. & ROQUES, B.P. (1986). Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex. Biochem. Biophys. Res. Commun., 137, 1167-1173.
9. HARPER, E.A., GRIFFIN, E.P., SHANKLEY, N.P. & BLACK, J.W. (1999). Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex. Br. J. Pharmacol., 126, 1496-1503.
10. HARPER, E.A., ROBERTS, S.P., SHANKLEY, N.P. & BLACK, J.W. (1996). Analysis of variation in L-365,260 competition curves in radioligand binding assays. Br. J. Pharmacol., 118, 1717-1726.
11. HELLMICH, M.R., RUI, X.L., HELLMICH, H.L., FLEMING, R.Y., EVERS, B.M. & TOWNSEND, Jr, C.M. (2000). Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J. Biol. Chem., 275, 32122-32128.
12. ITO, M., IWATA, N., TANIGUCHI, T., MURAYAMA, T., CHILHARA, K. & MATSUI, T. (1994). Functional characterisation of two cholecystokinin-B/gastrin receptor isoforms: a preferential splice donor site in the human receptor gene. Cell Growth Differ., 5, 1127-1135.
13. KOPIN, A.S., MCBRIDE, E.W., GORDON, M.C., QUINN, S.M. & BEINBORN, M. (1997). Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy. Proc. Natl. Acad. Sci. U.S.A., 94, 11043-11048.
14. LENA, I., SIMON, H., ROQUES, B.P. & DAUGE, V. (1999). Opposing effects of two CCK(B) agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat. Neuropharmacology, 38, 543-553.
15. MEESTER, B.J., SHANKLEY, N.P., WELSH, N.J., WOOD, J., MEIJLER, F.L. & BLACK, J.W. (1998). Pharmacological classification of adenosine receptors in the sinoatrial and atrioventricular nodes of the guinea-pig. Br. J. Pharmacol., 124, 685-692.
16. MIYAKE, A. (1995). A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon. Biochem. Biophys. Res. Commun., 208, 230-237.
17. MOTULSKY, H.J. (1999). Analyzing Data with GraphPad Prism, GraphPad Software, Inc., San Diego, CA, U.S.A.
18. ROBERTS, S.P., HARPER, E.A., WATT, G.F., GERSKOWITCH, V.P., HULL, R.A., SHANKLEY, N.P. & BLACK, J.W. (1996). Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Br. J. Pharmacol., 118, 1779-1789.
19. SANKARAN, H., GOLDFINE, I.D., DEVENEY, C.W., WONG, K.Y. & WILLIAMS, J.A. (1980). Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J. Biol. Chem., 255, 1849-1853.
20. SONG, I., BROWN, D.R., WILTSHIRE, R.N., GANTZ, I., TRENT, J.M. & YAMADA, T. (1993). The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc. Natl. Acad. Sci. U.S.A., 90, 9085-9089.
21. TAKINAMI, Y., YUKI, H., NISHIDA, A., AKUZAWA, S., UCHIDA, A., TAKEMOTO, Y., OHTA, M., SATOH, M., SEMPLE, G. & MIYATA, K. (1997). YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo. Aliment. Pharmacol. Ther., 11, 113-120.
22. WANK, S., PISEGNA, J.R. & POIROT, S. (1994). Functional significance of potential splice variants of the human cholecystokinin (CCK) B receptor. Gastroenterology, 106, A850.